<DOC>
	<DOC>NCT03021356</DOC>
	<brief_summary>The hemodynamic performance of two supraannular aortic xenografts (Trifecta, St. Jude Medical and Perimount Magna Ease, Edwards Lifescience) will be compared using rest- and stress echocardiography in a randomized prospective study. Furthermore, the prostheses' influence on postoperative outcome will be compared using spiroergometry, quality of life questionnaire and heart failure biomarkers.</brief_summary>
	<brief_title>Comparison of TrIfecta and Perimount Magna Ease</brief_title>
	<detailed_description />
	<criteria>Patients between 18 and 75 years Elective aortic valve replacement in patients with predominant aortic stenosis including concomitant CABG and/or atrial fibrillation ablation and/or supracoronary aortic replacement Informed consent including willingness for stress echocardiography, spiroergometry and quality of life examination after 6 months. Native German speakers (quality of life questionnaire in German language) Isolated aortic regurgitation Concomitant aortic regurgitation &gt; 2Â° Endocarditis LVEF &lt;40% Concomitant other valve surgery s/p valve surgery Contraindication for stress echocardiography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>